Menu

Intellia Therapeutics, Inc. NTLA

Full chart Compare
Set alert

Price alert · NTLA

All alert types
11.35 USD +0.25 (+2.25%)

At closeNov 6, 2026, 7:26 PM EST

11.39 +0.04 +0.34%

After hours · Nov 6, 7:26 PM ET

11.02 Day range 11.40
8.04 52-week range 17.84
YTD
+26.25%
1 year
-7.87%

Revenue & Expenses

Other Income → Expenses: $28.30MExpenses → Selling, General & Admin: $119.80MExpenses → Research & Development: $388.86MGross Profit → Expenses: $67.67MRevenue → Gross Profit: $67.67MNet Loss → Expenses: $412.69MOther Income$28.30MGross Profit$67.67MNet Loss$412.69MExpenses$508.66MSelling, General & Admin$119.80MResearch & Development$388.86MRevenue$67.67M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

NTLA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
67.67M57.88M36.27M52.12M33.05M
67.67M57.88M36.27M52.12M33.05M
67.67M57.88M36.27M52.12M33.05M
508.66M592.14M551.57M510.29M300.90M
388.86M466.31M435.07M419.98M229.81M
119.80M125.83M116.50M90.31M71.10M
-440.99M-534.26M-515.29M-458.16M-267.85M
-412.69M-519.02M-481.19M-474.19M-267.89M
-412.69M-519.02M-481.19M-474.19M-267.89M
-412.69M-519.02M-481.19M-474.19M-267.89M
-412.69M-519.02M-481.19M-474.19M-267.89M
-3.81-5.25-5.42-6.16-3.78
-3.81-5.25-5.42-6.16-3.78
-3.81-5.25-5.42-6.16-3.78
-412.69M-519.02M-481.19M-474.19M-267.89M
-412.69M-519.02M-481.19M-474.19M-267.89M
108.38M98.85M88.77M76.97M70.89M
108.38M98.85M88.77M76.97M70.89M